EVOKE PHARMA, INC. Unrecognized Tax Benefits
EVOKE PHARMA, INC. had Unrecognized Tax Benefits of $3.27 million as of 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2025-03-13
- 2024-12-31: Unrecognized Tax Benefits $3.27M.
- 2023-12-31: Unrecognized Tax Benefits $3.27M; Unrecognized Tax Benefits as first filed $2.00M.
- 2022-12-31: Unrecognized Tax Benefits $3.27M; Unrecognized Tax Benefits as first filed $2.00M.
- 2021-12-31: Unrecognized Tax Benefits $2.00M.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2024-12-31 | $3.27M 10-K · filed 2025-03-13 | |
| 2023-12-31 | $3.27M 10-K · filed 2025-03-13 | $2.00M 10-K · filed 2024-03-14 |
| 2022-12-31 | $3.27M 10-K · filed 2025-03-13 | $2.00M 10-K · filed 2023-03-21 |
| 2021-12-31 | $2.00M 10-K · filed 2023-03-21 | |
| 2020-12-31 | $2.00M 10-K · filed 2022-03-08 | |
| 2019-12-31 | $2.00M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $2.00M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $2.00M 10-K · filed 2019-03-06 | $1.96M 10-K · filed 2018-03-07 |
| 2016-12-31 | $1.96M 10-K · filed 2018-03-07 | |
| 2009-01-02 | $0.00 10-K · filed 2014-03-25 |